Aripiprazole lauroxil (US brand name Aristada Initio™) is an atypical antipsychotic. Here is basic information about this medication.
Aristada Initio™ given in combination with oral aripiprazole, is indicated for the initiation of Aristada® (long-acting IM monthly injection of aripiprazole lauroxil) for the treatment of schizophrenia in adults. It may also be given for re-starting Aristada® after a missed dose.
One 675 mg injection of Aristada Initio™ is administered intramuscularly with 30 mg of oral aripiprazole in conjunction with first dose of Aristada®.
Note: Aristada Initio™ should be given only as a single dose and not indicated for repeat dosing. It should be given as a IM injection in deltoid or gluteal muscle.
Dosage forms and strengths
Extended -release injectable suspension: 675 mg single-dose pre-filled syringe
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Copyright 2018, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information